UBS AM’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Buy
236,308
+2,233
+1% +$186K ﹤0.01% 896
2025
Q4
$17.9M Sell
234,075
-2,308
-1% -$177K ﹤0.01% 888
2025
Q3
$18.8M Buy
236,383
+195,716
+481% +$14.6M ﹤0.01% 846
2025
Q2
$2.85M Sell
40,667
-209,270
-84% -$15.3M ﹤0.01% 1978
2025
Q1
$18.5M Buy
249,937
+21,851
+10% +$1.54M ﹤0.01% 994
2024
Q4
$15.8M Sell
228,086
-14,240
-6% -$1.08M ﹤0.01% 1054
2024
Q3
$20.4M Buy
242,326
+186,238
+332% +$14.4M 0.01% 942
2024
Q2
$3.8M Sell
56,088
-134,049
-71% -$8.6M ﹤0.01% 1644
2024
Q1
$11.9M Sell
190,137
-6,938
-4% -$391K ﹤0.01% 941
2023
Q4
$11M Sell
197,075
-1,210
-0.6% -$64.1K ﹤0.01% 949
2023
Q3
$10.2M Buy
198,285
+2,021
+1% +$106K ﹤0.01% 946
2023
Q2
$10.1M Hold
196,264
﹤0.01% 972
2023
Q1
$10.1M Buy
196,264
+8,399
+4% +$458K ﹤0.01% 972
2022
Q4
$9.81M Buy
187,865
+1,549
+0.8% +$84.9K 0.01% 944
2022
Q3
$10.5M Sell
186,316
-14,770
-7% -$931K 0.01% 937
2022
Q2
$12.2M Sell
201,086
-16,674
-8% -$949K 0.01% 892
2022
Q1
$12.9M Buy
217,760
+4,425
+2% +$252K 0.01% 973
2021
Q4
$12.3M Buy
213,335
+22,376
+12% +$1.24M ﹤0.01% 1052
2021
Q3
$10.2M Buy
190,959
+7,454
+4% +$466K ﹤0.01% 1088
2021
Q2
$12.3M Sell
183,505
-11,203
-6% -$781K 0.01% 1049
2021
Q1
$14.1M Sell
194,708
-64,262
-25% -$4.48M 0.01% 967
2020
Q4
$17.9M Buy
258,970
+28,694
+12% +$1.82M 0.01% 873
2020
Q3
$13.9M Buy
230,276
+36,485
+19% +$2.25M 0.01% 862
2020
Q2
$11.8M Buy
193,791
+31,705
+20% +$1.74M 0.01% 864
2020
Q1
$8.03M Buy
162,086
+2,897
+2% +$220K 0.01% 918
2019
Q4
$13M Buy
159,189
+4,848
+3% +$397K 0.01% 872
2019
Q3
$12.7M Buy
154,341
+17,702
+13% +$1.44M 0.01% 877
2019
Q2
$10.7M Sell
136,639
-6,363
-4% -$494K 0.01% 937
2019
Q1
$11.2M Buy
143,002
+23,020
+19% +$1.83M 0.01% 901
2018
Q4
$9.06M Buy
119,982
+1,557
+1% +$117K 0.01% 905
2018
Q3
$8.95M Buy
118,425
+4,300
+4% +$328K 0.01% 962
2018
Q2
$8.41M Buy
114,125
+1,557
+1% +$110K 0.01% 988
2018
Q1
$7.57M Buy
112,568
+20,239
+22% +$1.38M 0.01% 1008
2017
Q4
$6.96M Buy
92,329
+12,130
+15% +$941K 0.01% 1005
2017
Q3
$6.2M Buy
80,199
+3,601
+5% +$282K 0.01% 1015
2017
Q2
$6.07M Buy
76,598
+4,384
+6% +$332K 0.01% 993
2017
Q1
$5.24M Buy
72,214
+11,776
+19% +$863K 0.01% 1009
2016
Q4
$4.48M Sell
60,438
-1,245
-2% -$91.4K 0.01% 1018
2016
Q3
$4.84M Buy
61,683
+2,665
+5% +$210K 0.01% 1028
2016
Q2
$4.43M Buy
59,018
+4,931
+9% +$342K 0.01% 1052
2016
Q1
$3.6M Sell
54,087
-15,373
-22% -$950K ﹤0.01% 1130
2015
Q4
$4.23M Buy
69,460
+4,890
+8% +$292K ﹤0.01% 1131
2015
Q3
$3.71M Buy
64,570
+13,062
+25% +$790K ﹤0.01% 1162
2015
Q2
$3.21M Buy
51,508
+3,690
+8% +$247K ﹤0.01% 1199
2015
Q1
$3.4M Buy
47,818
+2,800
+6% +$202K ﹤0.01% 1158
2014
Q4
$3.15M Buy
45,018
+9,300
+26% +$604K ﹤0.01% 1162
2014
Q3
$2.04M Sell
35,718
-1,600
-4% -$99.2K ﹤0.01% 1294
2014
Q2
$2.33M Buy
37,318
+3,700
+11% +$228K ﹤0.01% 1275
2014
Q1
$2.03M Sell
33,618
-1,770
-5% -$107K ﹤0.01% 1306
2013
Q4
$1.99M Buy
35,388
+5,800
+20% +$345K ﹤0.01% 1276
2013
Q3
$1.68M Sell
29,588
-3,200
-10% -$191K ﹤0.01% 1304
2013
Q2
$1.96M Buy
+32,788
New +$2.12M ﹤0.01% 1229

Other funds holding NHI

UBS AM's NHI Position: Q1 2026 in Review

UBS AM increased its National Health Investors (NHI) stake by 0.95% in Q1 2026, buying an estimated $186K and bringing the position to 236,308 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #896.

UBS AM first reported a position in NHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.4M in Q3 2024. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • UBS AM held 236,308 shares of National Health Investors worth $19.1M as of Q1 2026.
  • UBS AM bought 2,233 National Health Investors shares in Q1 2026, an estimated $186K.
  • National Health Investors made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #896 holding.
  • UBS AM first reported a position in National Health Investors in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's National Health Investors position peaked at $20.4M in Q3 2024.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.